Insight

Sep 29, 2024, 16:26

Donald McDonnell: Exploring the interactions between estrogens and tumor immunity

Donald McDonnell, Professor at Department of Pharmacology and Cancer Biology at Duke University School of Medicine, posted the following on LinkedIn:

“Another in a series of papers from our group that is exploring the interactions between estrogens and tumor immunity. These preclinical studies are now being translated to the clinic.”

Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth

Authors: Sandeep Artham, Patrick K. Juras, Aditi Goyal, Prabuddha Chakraborty, Jovita Byemerwa, Siyao Liu, Suzanne E. Wardell, Binita Chakraborty, Daniel Crowder, Felicia Lim, Corinne H. Strawser, Madeline Newlin, Alessandro Racioppi, Susan Dent, Babak Mirminachi, Jatin Roper, Charles M. Perou, Ching-Yi Chang, and Donald P. McDonnell

Source: Donald McDonnell/LinkedIn

Aditi Goyal Alessandro Racioppi Babak Mirminachi Binita Chakraborty breast tumor growth cancer Charles M. Perou Ching-Yi Chang clinical translation Corinne H. Strawser Daniel Crowder Department of Pharmacology and Cancer Biology Donald McDonnell Duke University School of Medicine estrogen signaling Felicia Lim Jatin Roper Jovita Byemerwa Madeline Newlin OncoDaily Oncology Patrick K. Juras Prabuddha Chakraborty preclinical studies Sandeep Artham Siyao Liu Susan Dent Suzanne E. Wardell tumor immunity

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage